Teneligliptin (MP-513) hydrobromide is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50s: 0.37 and 0.29 nM for the human and rat DPP-4, respectively). Teneligliptin hydrobromide improves blood glucose levels and can be used in researches related to type 2 diabetes mellitus[1][2][3][4][5][6][7][8].
Molekulargewicht:
628.86
Reinheit:
99.99
CAS Nummer:
[906093-29-6]
Formel:
C22H30N6OS.5/2HBr
Target-Kategorie:
AMPK,Apoptosis,Dipeptidyl Peptidase,Interleukin Related,JNK,NF-kappaB,NOD-like Receptor (NLR),p38 MAPK,Reactive Oxygen Species (ROS)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten